Survey Shows High Level of Parental Hesitancy for COVID-19 Vaccines
The survey asked about the likelihood of both child and parental vaccination, perceptions about the vaccines and the level of trust in various sources of information.
Vaccines
New Data Show Janssen Booster Shot Increases Protection Against COVID-19
Vaccine effectiveness was reported to be 79% for COVID-19-related infections and 81% for COVID-19-related hospitalizations, according to real-world data.
Lower Dose COVID-19 Vaccine Appears Safe, Immunogenic in Children 5 to 11 Years Old
Participants 5 to 11 years of age received a 2-dose regimen of 10mcg administered 21 days apart.
Incidence of Vaccine-Related and Nonvaccine Human Papillomavirus Types Among Adolescent Girls, Young Women in New York City
Researchers conducted a study to determine the rates of human papillomavirus (HPV) infection among adolescent girls and young women in New York City who received the HPV vaccine following its approval in 2007.
ACIP: Updated Vaccine Guidance for the 2021-2022 Influenza Season
Routine annual vaccination is recommended for all patients 6 months of age and older who have no contraindications.
Pfizer, BioNTech Submit Supplemental BLA for COVID-19 Vaccine Booster
The application includes data from a phase 3 trial that evaluated a booster dose of Comirnaty in 306 adult participants 18 to 55 years of age who were previously vaccinated with a 2-dose primary regimen.
Biologics License Application for Moderna COVID-19 Vaccine Submitted to FDA
The application includes data from the phase 3 COVE study that evaluated the Moderna COVID-19 vaccine in 30,420 adults 18 years of age and older.
CDC: COVID-19 Vaccination Recommended for Pregnant People
The recommendation aligns with that from the American College of Obstetricians and Gynecologists and the Society for Maternal Fetal Medicine.
Moderna COVID-19 Vaccine Maintains Efficacy 6 Months After Second Dose
The efficacy data was based on a final analysis of the phase 3 COVE study which evaluated the mRNA-1273 vaccine in more than 30,000 adults aged 18 years and older.
Shingrix Approved to Prevent Shingles in Immunocompromised Adults
Previously, the vaccine was only approved for adults 50 years of age and older.
- Loading...
Loading...
Next post in News
Loading... 
Loading...